FDA-compliant ophthalmic device manufacturer scaling across 130+ markets
Aurolab manufactures intraocular lenses, surgical sutures, blades, and related medical consumables under FDA, EU GMP, and WHO GMP standards, exporting to 130+ countries with primary focus on India, Africa, Latin America, and Southeast Asia. Active hiring across sales, HR, and marketing—with senior roles outnumbering junior—signals growth acceleration, while internal projects on recruitment analytics and cost variance analysis reveal operational scaling bottlenecks in talent acquisition and supply-chain cost control.
Founded in 1992 and headquartered in Madurai, Tamil Nadu, Aurolab is a nonprofit manufacturer of ophthalmic consumables serving mid-market and emerging-market healthcare systems. The product range spans intraocular lenses, surgical sutures, pharmaceutical products, surgical blades, and equipment, with recent diversification into cardiovascular sutures, microsurgical hand sutures, and antiseptic solutions. Manufacturing runs on regulated production lines certified to US FDA, EU GMP, and WHO GMP standards. The company operates a 1,001–5,000-person workforce structured around production, regulatory compliance, and go-to-market functions, with distribution concentrated in India, Africa, Latin America, and Central America. Strategic expansion into European and developed markets is planned as a path to sustain cross-subsidized pricing in lower-income geographies.
Intraocular lenses and ophthalmic surgical consumables (sutures, blades, equipment, pharmaceuticals) manufactured to FDA, EU GMP, and WHO GMP standards, with recent expansion into cardiovascular and microsurgical products.
130+ countries, with primary focus on India, Africa, Latin America, Central America, and Southeast Asia. Strategic expansion into European and other developed markets is planned.
Other companies in the same industry, closest in size